CAR-T(CAR-T)细胞疗法在非肿瘤性疾病中的应用
Chimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases.
CAR-T(CAR-T)细胞在血液系统恶性肿瘤中的应用推动了这种免疫治疗形式的显著进展。
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Advanced strategies in improving the immunotherapeutic effect of CAR-T cell therapy.
Advanced strategies in improving the immunotherapeutic effect of CAR-T cell therapy.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
嵌合抗原受体(CAR-T)细胞疗法是一种新开发的免疫治疗策略,在血液系统恶性肿瘤的治疗中取得了令人满意的效果。然而,在CAR-T 细胞疗法作为癌症治疗方法广泛应用于临床之前,一些与CAR-T 细胞疗法相关的不良反应必须得到解决。此外,CAR-T 细胞疗法在实体瘤治疗中的应用受到诸多限制的阻碍。因此,探索新的策略以提高CAR-T 细胞疗法的治疗效果至关重要。在这篇综述中,我们总结了近期开发的旨在优化CAR-T 细胞生成和提高CAR-T 细胞疗法抗肿瘤效率的策略。此外,还重点介绍了CAR-T 细胞疗法新靶点的发现以及CAR-T 细胞疗法与化疗、放疗、癌症疫苗和纳米材料联合治疗的策略。
Chimeric antigen receptor (CAR-T) cell therapy is a newly developed immunotherapy strategy and has achieved satisfactory outcomes in the treatment of hematological malignancies.
However, some adverse effects related to CAR-T cell therapy have to be resolved before it is widely used in clinics as a cancer treatment.
Furthermore, the application of CAR-T cell therapy in the treatment of solid tumors has been hampered by numerous limitations.
Therefore, it is essential to explore novel strategies to improve the therapeutic effect of CAR-T cell therapy. In this review, we summarized the recently developed strategies aimed at optimizing the generation of CAR-T cells and improving the anti-tumor efficiency of CAR-T cell therapy.
Furthermore, the discovery of new targets for CAR-T cell therapy and the combined treatment strategies of CAR-T cell therapy with chemotherapy, radiotherapy, cancer vaccines and nanomaterials are highlighted.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。